Amicus Therapeutics (FOLD) Fails to deliver data

Key failure to deliver metrics for Amicus Therapeutics :

• Last SEC data release: 2025-11-14
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: A$7.34 M
• Last 12 months FTD volume: A$13.62 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Amicus Therapeutics (FOLD) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Amicus Therapeutics (FOLD) - since 2013

Amicus Therapeutics (FOLD) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Biogen BIIB	A$22.86 M	A$94.5 M	🇺🇸 USA
BioMarin Pharmaceutical BMRN	A$2.8 M	A$17.38 M	🇺🇸 USA
Esperion Therapeutics ESPR	A$3.3 M	A$9.95 M	🇺🇸 USA
GlaxoSmithKline GSK	A$72.01 M	A$0.40 B	🇬🇧 UK
Lexicon Pharmaceuticals LXRX	A$0.58 M	A$12.15 M	🇺🇸 USA
Novo Nordisk NVO	A$0.15 B	A$0.46 B	🇩🇰 Denmark